Literature DB >> 3981956

Low-dose dexamethasone suppression of urinary free cortisol in the differential diagnosis between Cushing's syndrome and obesity.

A Kreze, J Velemínský, E Spirová.   

Abstract

Urinary free cortisol (UFC) was measured in the basal state and on 2nd day of the low-dose dexamethasone (2 mg daily for 2 days) suppression test (LDDT) in 182 subjects. At first examination the results were in good agreement with the definite diagnosis in 21 of 27 patients with Cushing's syndrome (CS) and in 145 out of 155 obese subjects. In two obese subjects the basal UFC was increased and the response to the test insufficient. At re-examination their laboratory findings became normal. In 14 subjects the basal UFC was increased but the response to the test was normal. With nine of them, repeated examinations were performed over a period of 1-7 years. Six subjects progressed into obvious CS, while in two hypercortisolism spontaneously regressed and in one it remained unchanged. The combination of elevated basal UFC with a normal suppressibility during the LDDT is considered a borderline adrenocortical impairment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3981956     DOI: 10.1007/bf01732174

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  10 in total

1.  Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome.

Authors:  G W LIDDLE
Journal:  J Clin Endocrinol Metab       Date:  1960-12       Impact factor: 5.958

2.  Studies on the "low dose" suppressible Cushing's disease.

Authors:  N Shimizu; H Yoshida
Journal:  Endocrinol Jpn       Date:  1976-12

3.  A radioimmunoassay for cortisol in plasma and urine.

Authors:  H J Ruder; R L Guy; M B Lipsett
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

4.  Cushing's syndrome: a prospective study of diagnostic methods.

Authors:  R L Eddy; A L Jones; P F Gilliland; J D Ibarra; J Q Thompson; J F MacMurry
Journal:  Am J Med       Date:  1973-11       Impact factor: 4.965

5.  Cushing's syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis.

Authors:  C W Burke; C G Beardwell
Journal:  Q J Med       Date:  1973-01

6.  Urinary free corticoids: an evaluation of their usefulness in the diagnosis of Cushing's syndrome.

Authors:  G Vidal Trecan; M H Laudat; P Thomopoulos; J P Luton; H Bricaire
Journal:  Acta Endocrinol (Copenh)       Date:  1983-05

7.  Intermittent Cushing's syndrome with an empty sella turcica.

Authors:  D J Smith; P C Kohler; R Helminiak; J Carroll
Journal:  Arch Intern Med       Date:  1982-11

8.  Plasma corticosteroids determined by use of corticosteroid-binding globulin and dextran-coated charcoal.

Authors:  C A Nugent; D M Mayes
Journal:  J Clin Endocrinol Metab       Date:  1966-10       Impact factor: 5.958

9.  Apparently normal pituitary-adrenal suppressibility in Cushing's syndrome: dexamethasone metabolism and plasma levels.

Authors:  A W Meikle; L G Lagerquist; F H Tyler
Journal:  J Lab Clin Med       Date:  1975-09

10.  Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone.

Authors:  A W Meikle
Journal:  Clin Endocrinol (Oxf)       Date:  1982-04       Impact factor: 3.478

  10 in total
  1 in total

Review 1.  [Factors interfering with the dexamethasone suppression test].

Authors:  R Liebl
Journal:  Klin Wochenschr       Date:  1986-06-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.